Pediatric Digestive Drugs Comprehensive Study by Type (Global Pediatric Digestive Drugs Market Segment Percentages, by Type, 2021 (%)), Application (Gastroenteritis, Celiac disease, Crohn’s disease, Irritable bowel syndrome, Others.), Route of Administration (Rectal, Parenteral, Oral), Form (Tablets, Liquids), Distribution Channel (Hospital pharmacies, Online pharmacies, Retail pharmacies) Players and Region - Global Market Outlook to 2027

Pediatric Digestive Drugs Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Pediatric Digestive Drugs
Pediatric digestive drug as the names suggest is used to treat digestive problems in children. An increase in gastronomical problems due to lifestyle changes has been contributing to the market growth of Pediatric digestive drugs. The efforts by the governments by investments and supports to develop the life science industry have been showing a positive impact on R&D and also a massive positive growth has been seen due to investments by pharmaceutical companies to develop better drugs to solve selective disease to improve Pediatric health. The disruption of E-commerce and online pharmacy has been a contributing factor to the growth and better opportunities to reach patients directly.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The market has seen a massive investment in R&D and artificial intelligence which has driven the market growth. Massive investments and disruption of the digitization in industries by the E-commerce and other applications market have seen a majority of providers enter the distribution channel has made it convenient to reach end-user. This has made new entrances grab a good position in the market. Whereas the big players have tried to develop by mergers and acquisitions and investments in developing better technology to keep up with the competition and hold a higher position in the market. Analyst at AMA Research estimates that Europe Players will contribute the maximum growth to Global Pediatric Digestive Drugs market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Novartis (Switzerland), Gilead Sciences Inc (United States), Abbvie (Allergan) (Ireland), Bristol Myers Squibb (United States), Takeda (Japan), Alcon Labs Inc (Switzerland), Biomarin Pharm (United States), Currax Pharmaceuticals LLC (United States), Helsinn (Switzerland) and Roche Holdings (Hoffmann La Roche) (Switzerland) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Pediatric Digestive Drugs market by Type (Global Pediatric Digestive Drugs Market Segment Percentages, by Type, 2021 (%)), Application (Gastroenteritis, Celiac disease, Crohn’s disease, Irritable bowel syndrome and Others.) and Region.



On the basis of geography, the market of Pediatric Digestive Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Route of Administration, the sub-segment i.e. Rectal will boost the Pediatric Digestive Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Form, the sub-segment i.e. Tablets will boost the Pediatric Digestive Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital pharmacies will boost the Pediatric Digestive Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
AbbVie, a research-based global biopharmaceutical company, announced on May 2020 that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.
Takeda Pharmaceutical Company Limited on September 2021 announced that it has received approval from the Japan Ministry of Health, Labour and Welfare to manufacture and market Alofisel (darvadstrocel) - development code: Cx601 - for the treatment of complex perianal fistulas in patients with non-active or mildly active luminal Crohn’s disease (CD).3 This product is indicated for the treatment of patients who have shown an inadequate response to at least one existing medicinal treatment.
FDA ensures the quality of drug products by carefully monitoring drug manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations. The CGMP regulations for drugs contain minimum requirements for the methods, facilities, and controls used in the manufacturing, processing, and packing of a drug product. The regulations make sure that a product is safe for use, and that it has the ingredients and strength it claims to have. and The approval process for new and generic drug marketing applications includes a review of the manufacturer's compliance with the CGMPs. FDA assessors and investigators determine whether the firm has the necessary facilities, equipment, and ability to manufacture the drug it intends to market.

Market Drivers
  • The Increasing Rate of Government Investments and Support in the Life Science Industry Has Been Driving the Market Growth.

Opportunities
  • Increase in Investment by Pharma Companies in R&D to Provide Different Types of Drugs to Deal With Respective Disease Types.

Restraints
  • Increasing Number of Counterfeit

Challenges
  • High Cost of Raw Material


Key Target Audience
Pharmaceutical companies, New Entrants and Investors, Legalized Cannabis Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Global Pediatric Digestive Drugs Market Segment Percentages, by Type, 2021 (%)
By Application
  • Gastroenteritis
  • Celiac disease
  • Crohn’s disease
  • Irritable bowel syndrome
  • Others.
By Route of Administration
  • Rectal
  • Parenteral
  • Oral

By Form
  • Tablets
  • Liquids

By Distribution Channel
  • Hospital pharmacies
  • Online pharmacies
  • Retail pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Increasing Rate of Government Investments and Support in the Life Science Industry Has Been Driving the Market Growth.
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Raw Material
    • 3.4. Market Trends
      • 3.4.1. Increasing Rate of Gastronomical Diseases in young Crowd.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pediatric Digestive Drugs, by Type, Application, Route of Administration, Form, Distribution Channel and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Pediatric Digestive Drugs (Value)
      • 5.2.1. Global Pediatric Digestive Drugs by: Type (Value)
        • 5.2.1.1. Global Pediatric Digestive Drugs Market Segment Percentages, by Type, 2021 (%)
      • 5.2.2. Global Pediatric Digestive Drugs by: Application (Value)
        • 5.2.2.1. Gastroenteritis
        • 5.2.2.2. Celiac disease
        • 5.2.2.3. Crohn’s disease
        • 5.2.2.4. Irritable bowel syndrome
        • 5.2.2.5. Others.
      • 5.2.3. Global Pediatric Digestive Drugs by: Route of Administration (Value)
        • 5.2.3.1. Rectal
        • 5.2.3.2. Parenteral
        • 5.2.3.3. Oral
      • 5.2.4. Global Pediatric Digestive Drugs by: Form (Value)
        • 5.2.4.1. Tablets
        • 5.2.4.2. Liquids
      • 5.2.5. Global Pediatric Digestive Drugs by: Distribution Channel (Value)
        • 5.2.5.1. Hospital pharmacies
        • 5.2.5.2. Online pharmacies
        • 5.2.5.3. Retail pharmacies
      • 5.2.6. Global Pediatric Digestive Drugs Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Pediatric Digestive Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Gilead Sciences Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbvie (Allergan) (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bristol Myers Squibb (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Takeda (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Alcon Labs Inc (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Biomarin Pharm (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Currax Pharmaceuticals LLC (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Helsinn (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Roche Holdings (Hoffmann La Roche) (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pediatric Digestive Drugs Sale, by Type, Application, Route of Administration, Form, Distribution Channel and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Pediatric Digestive Drugs (Value)
      • 7.2.1. Global Pediatric Digestive Drugs by: Type (Value)
        • 7.2.1.1. Global Pediatric Digestive Drugs Market Segment Percentages, by Type, 2021 (%)
      • 7.2.2. Global Pediatric Digestive Drugs by: Application (Value)
        • 7.2.2.1. Gastroenteritis
        • 7.2.2.2. Celiac disease
        • 7.2.2.3. Crohn’s disease
        • 7.2.2.4. Irritable bowel syndrome
        • 7.2.2.5. Others.
      • 7.2.3. Global Pediatric Digestive Drugs by: Route of Administration (Value)
        • 7.2.3.1. Rectal
        • 7.2.3.2. Parenteral
        • 7.2.3.3. Oral
      • 7.2.4. Global Pediatric Digestive Drugs by: Form (Value)
        • 7.2.4.1. Tablets
        • 7.2.4.2. Liquids
      • 7.2.5. Global Pediatric Digestive Drugs by: Distribution Channel (Value)
        • 7.2.5.1. Hospital pharmacies
        • 7.2.5.2. Online pharmacies
        • 7.2.5.3. Retail pharmacies
      • 7.2.6. Global Pediatric Digestive Drugs Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pediatric Digestive Drugs: by Type(USD Million)
  • Table 2. Pediatric Digestive Drugs Global Pediatric Digestive Drugs Market Segment Percentages, by Type, 2021 (%) , by Region USD Million (2016-2021)
  • Table 3. Pediatric Digestive Drugs: by Application(USD Million)
  • Table 4. Pediatric Digestive Drugs Gastroenteritis , by Region USD Million (2016-2021)
  • Table 5. Pediatric Digestive Drugs Celiac disease , by Region USD Million (2016-2021)
  • Table 6. Pediatric Digestive Drugs Crohn’s disease , by Region USD Million (2016-2021)
  • Table 7. Pediatric Digestive Drugs Irritable bowel syndrome , by Region USD Million (2016-2021)
  • Table 8. Pediatric Digestive Drugs Others. , by Region USD Million (2016-2021)
  • Table 9. Pediatric Digestive Drugs: by Route of Administration(USD Million)
  • Table 10. Pediatric Digestive Drugs Rectal , by Region USD Million (2016-2021)
  • Table 11. Pediatric Digestive Drugs Parenteral , by Region USD Million (2016-2021)
  • Table 12. Pediatric Digestive Drugs Oral , by Region USD Million (2016-2021)
  • Table 13. Pediatric Digestive Drugs: by Form(USD Million)
  • Table 14. Pediatric Digestive Drugs Tablets , by Region USD Million (2016-2021)
  • Table 15. Pediatric Digestive Drugs Liquids , by Region USD Million (2016-2021)
  • Table 16. Pediatric Digestive Drugs: by Distribution Channel(USD Million)
  • Table 17. Pediatric Digestive Drugs Hospital pharmacies , by Region USD Million (2016-2021)
  • Table 18. Pediatric Digestive Drugs Online pharmacies , by Region USD Million (2016-2021)
  • Table 19. Pediatric Digestive Drugs Retail pharmacies , by Region USD Million (2016-2021)
  • Table 20. South America Pediatric Digestive Drugs, by Country USD Million (2016-2021)
  • Table 21. South America Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 22. South America Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 23. South America Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 24. South America Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 25. South America Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 26. Brazil Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 27. Brazil Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 28. Brazil Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 29. Brazil Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 30. Brazil Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 31. Argentina Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 32. Argentina Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 33. Argentina Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 34. Argentina Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 35. Argentina Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 36. Rest of South America Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 37. Rest of South America Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 38. Rest of South America Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 39. Rest of South America Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 40. Rest of South America Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 41. Asia Pacific Pediatric Digestive Drugs, by Country USD Million (2016-2021)
  • Table 42. Asia Pacific Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 43. Asia Pacific Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 44. Asia Pacific Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 45. Asia Pacific Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 46. Asia Pacific Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 47. China Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 48. China Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 49. China Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 50. China Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 51. China Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 52. Japan Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 53. Japan Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 54. Japan Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 55. Japan Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 56. Japan Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 57. India Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 58. India Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 59. India Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 60. India Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 61. India Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 62. South Korea Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 63. South Korea Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 64. South Korea Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 65. South Korea Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 66. South Korea Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 67. Taiwan Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 68. Taiwan Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 69. Taiwan Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 70. Taiwan Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 71. Taiwan Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 72. Australia Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 73. Australia Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 74. Australia Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 75. Australia Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 76. Australia Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 77. Rest of Asia-Pacific Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 78. Rest of Asia-Pacific Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 79. Rest of Asia-Pacific Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 80. Rest of Asia-Pacific Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 81. Rest of Asia-Pacific Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 82. Europe Pediatric Digestive Drugs, by Country USD Million (2016-2021)
  • Table 83. Europe Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 84. Europe Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 85. Europe Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 86. Europe Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 87. Europe Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 88. Germany Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 89. Germany Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 90. Germany Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 91. Germany Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 92. Germany Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 93. France Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 94. France Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 95. France Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 96. France Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 97. France Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 98. Italy Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 99. Italy Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 100. Italy Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 101. Italy Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 102. Italy Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 103. United Kingdom Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 104. United Kingdom Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 105. United Kingdom Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 106. United Kingdom Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 107. United Kingdom Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 108. Netherlands Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 109. Netherlands Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 110. Netherlands Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 111. Netherlands Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 112. Netherlands Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 113. Rest of Europe Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 114. Rest of Europe Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 115. Rest of Europe Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 116. Rest of Europe Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 117. Rest of Europe Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 118. MEA Pediatric Digestive Drugs, by Country USD Million (2016-2021)
  • Table 119. MEA Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 120. MEA Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 121. MEA Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 122. MEA Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 123. MEA Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 124. Middle East Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 125. Middle East Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 126. Middle East Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 127. Middle East Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 128. Middle East Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 129. Africa Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 130. Africa Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 131. Africa Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 132. Africa Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 133. Africa Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 134. North America Pediatric Digestive Drugs, by Country USD Million (2016-2021)
  • Table 135. North America Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 136. North America Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 137. North America Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 138. North America Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 139. North America Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 140. United States Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 141. United States Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 142. United States Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 143. United States Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 144. United States Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 145. Canada Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 146. Canada Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 147. Canada Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 148. Canada Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 149. Canada Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 150. Mexico Pediatric Digestive Drugs, by Type USD Million (2016-2021)
  • Table 151. Mexico Pediatric Digestive Drugs, by Application USD Million (2016-2021)
  • Table 152. Mexico Pediatric Digestive Drugs, by Route of Administration USD Million (2016-2021)
  • Table 153. Mexico Pediatric Digestive Drugs, by Form USD Million (2016-2021)
  • Table 154. Mexico Pediatric Digestive Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Pediatric Digestive Drugs: by Type(USD Million)
  • Table 166. Pediatric Digestive Drugs Global Pediatric Digestive Drugs Market Segment Percentages, by Type, 2021 (%) , by Region USD Million (2022-2027)
  • Table 167. Pediatric Digestive Drugs: by Application(USD Million)
  • Table 168. Pediatric Digestive Drugs Gastroenteritis , by Region USD Million (2022-2027)
  • Table 169. Pediatric Digestive Drugs Celiac disease , by Region USD Million (2022-2027)
  • Table 170. Pediatric Digestive Drugs Crohn’s disease , by Region USD Million (2022-2027)
  • Table 171. Pediatric Digestive Drugs Irritable bowel syndrome , by Region USD Million (2022-2027)
  • Table 172. Pediatric Digestive Drugs Others. , by Region USD Million (2022-2027)
  • Table 173. Pediatric Digestive Drugs: by Route of Administration(USD Million)
  • Table 174. Pediatric Digestive Drugs Rectal , by Region USD Million (2022-2027)
  • Table 175. Pediatric Digestive Drugs Parenteral , by Region USD Million (2022-2027)
  • Table 176. Pediatric Digestive Drugs Oral , by Region USD Million (2022-2027)
  • Table 177. Pediatric Digestive Drugs: by Form(USD Million)
  • Table 178. Pediatric Digestive Drugs Tablets , by Region USD Million (2022-2027)
  • Table 179. Pediatric Digestive Drugs Liquids , by Region USD Million (2022-2027)
  • Table 180. Pediatric Digestive Drugs: by Distribution Channel(USD Million)
  • Table 181. Pediatric Digestive Drugs Hospital pharmacies , by Region USD Million (2022-2027)
  • Table 182. Pediatric Digestive Drugs Online pharmacies , by Region USD Million (2022-2027)
  • Table 183. Pediatric Digestive Drugs Retail pharmacies , by Region USD Million (2022-2027)
  • Table 184. South America Pediatric Digestive Drugs, by Country USD Million (2022-2027)
  • Table 185. South America Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 186. South America Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 187. South America Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 188. South America Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 189. South America Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 190. Brazil Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 191. Brazil Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 192. Brazil Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 193. Brazil Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 194. Brazil Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 195. Argentina Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 196. Argentina Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 197. Argentina Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 198. Argentina Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 199. Argentina Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 200. Rest of South America Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 201. Rest of South America Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 202. Rest of South America Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 203. Rest of South America Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 204. Rest of South America Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 205. Asia Pacific Pediatric Digestive Drugs, by Country USD Million (2022-2027)
  • Table 206. Asia Pacific Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 207. Asia Pacific Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 208. Asia Pacific Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 209. Asia Pacific Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 210. Asia Pacific Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 211. China Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 212. China Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 213. China Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 214. China Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 215. China Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 216. Japan Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 217. Japan Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 218. Japan Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 219. Japan Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 220. Japan Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 221. India Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 222. India Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 223. India Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 224. India Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 225. India Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 226. South Korea Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 227. South Korea Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 228. South Korea Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 229. South Korea Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 230. South Korea Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 231. Taiwan Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 232. Taiwan Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 233. Taiwan Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 234. Taiwan Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 235. Taiwan Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 236. Australia Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 237. Australia Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 238. Australia Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 239. Australia Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 240. Australia Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 241. Rest of Asia-Pacific Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 242. Rest of Asia-Pacific Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 243. Rest of Asia-Pacific Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 244. Rest of Asia-Pacific Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 245. Rest of Asia-Pacific Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 246. Europe Pediatric Digestive Drugs, by Country USD Million (2022-2027)
  • Table 247. Europe Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 248. Europe Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 249. Europe Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 250. Europe Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 251. Europe Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 252. Germany Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 253. Germany Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 254. Germany Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 255. Germany Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 256. Germany Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 257. France Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 258. France Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 259. France Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 260. France Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 261. France Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 262. Italy Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 263. Italy Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 264. Italy Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 265. Italy Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 266. Italy Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 267. United Kingdom Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 268. United Kingdom Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 269. United Kingdom Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 270. United Kingdom Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 271. United Kingdom Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 272. Netherlands Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 273. Netherlands Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 274. Netherlands Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 275. Netherlands Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 276. Netherlands Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 277. Rest of Europe Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 278. Rest of Europe Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 279. Rest of Europe Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 280. Rest of Europe Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 281. Rest of Europe Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 282. MEA Pediatric Digestive Drugs, by Country USD Million (2022-2027)
  • Table 283. MEA Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 284. MEA Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 285. MEA Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 286. MEA Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 287. MEA Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 288. Middle East Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 289. Middle East Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 290. Middle East Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 291. Middle East Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 292. Middle East Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 293. Africa Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 294. Africa Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 295. Africa Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 296. Africa Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 297. Africa Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 298. North America Pediatric Digestive Drugs, by Country USD Million (2022-2027)
  • Table 299. North America Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 300. North America Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 301. North America Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 302. North America Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 303. North America Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 304. United States Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 305. United States Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 306. United States Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 307. United States Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 308. United States Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 309. Canada Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 310. Canada Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 311. Canada Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 312. Canada Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 313. Canada Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 314. Mexico Pediatric Digestive Drugs, by Type USD Million (2022-2027)
  • Table 315. Mexico Pediatric Digestive Drugs, by Application USD Million (2022-2027)
  • Table 316. Mexico Pediatric Digestive Drugs, by Route of Administration USD Million (2022-2027)
  • Table 317. Mexico Pediatric Digestive Drugs, by Form USD Million (2022-2027)
  • Table 318. Mexico Pediatric Digestive Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 319. Research Programs/Design for This Report
  • Table 320. Key Data Information from Secondary Sources
  • Table 321. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pediatric Digestive Drugs: by Type USD Million (2016-2021)
  • Figure 5. Global Pediatric Digestive Drugs: by Application USD Million (2016-2021)
  • Figure 6. Global Pediatric Digestive Drugs: by Route of Administration USD Million (2016-2021)
  • Figure 7. Global Pediatric Digestive Drugs: by Form USD Million (2016-2021)
  • Figure 8. Global Pediatric Digestive Drugs: by Distribution Channel USD Million (2016-2021)
  • Figure 9. South America Pediatric Digestive Drugs Share (%), by Country
  • Figure 10. Asia Pacific Pediatric Digestive Drugs Share (%), by Country
  • Figure 11. Europe Pediatric Digestive Drugs Share (%), by Country
  • Figure 12. MEA Pediatric Digestive Drugs Share (%), by Country
  • Figure 13. North America Pediatric Digestive Drugs Share (%), by Country
  • Figure 14. Global Pediatric Digestive Drugs share by Players 2021 (%)
  • Figure 15. Global Pediatric Digestive Drugs share by Players (Top 3) 2021(%)
  • Figure 16. Global Pediatric Digestive Drugs share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. Novartis (Switzerland) Revenue: by Geography 2021
  • Figure 20. Gilead Sciences Inc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Gilead Sciences Inc (United States) Revenue: by Geography 2021
  • Figure 22. Abbvie (Allergan) (Ireland) Revenue, Net Income and Gross profit
  • Figure 23. Abbvie (Allergan) (Ireland) Revenue: by Geography 2021
  • Figure 24. Bristol Myers Squibb (United States) Revenue, Net Income and Gross profit
  • Figure 25. Bristol Myers Squibb (United States) Revenue: by Geography 2021
  • Figure 26. Takeda (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Takeda (Japan) Revenue: by Geography 2021
  • Figure 28. Alcon Labs Inc (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Alcon Labs Inc (Switzerland) Revenue: by Geography 2021
  • Figure 30. Biomarin Pharm (United States) Revenue, Net Income and Gross profit
  • Figure 31. Biomarin Pharm (United States) Revenue: by Geography 2021
  • Figure 32. Currax Pharmaceuticals LLC (United States) Revenue, Net Income and Gross profit
  • Figure 33. Currax Pharmaceuticals LLC (United States) Revenue: by Geography 2021
  • Figure 34. Helsinn (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Helsinn (Switzerland) Revenue: by Geography 2021
  • Figure 36. Roche Holdings (Hoffmann La Roche) (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Roche Holdings (Hoffmann La Roche) (Switzerland) Revenue: by Geography 2021
  • Figure 38. Global Pediatric Digestive Drugs: by Type USD Million (2022-2027)
  • Figure 39. Global Pediatric Digestive Drugs: by Application USD Million (2022-2027)
  • Figure 40. Global Pediatric Digestive Drugs: by Route of Administration USD Million (2022-2027)
  • Figure 41. Global Pediatric Digestive Drugs: by Form USD Million (2022-2027)
  • Figure 42. Global Pediatric Digestive Drugs: by Distribution Channel USD Million (2022-2027)
  • Figure 43. South America Pediatric Digestive Drugs Share (%), by Country
  • Figure 44. Asia Pacific Pediatric Digestive Drugs Share (%), by Country
  • Figure 45. Europe Pediatric Digestive Drugs Share (%), by Country
  • Figure 46. MEA Pediatric Digestive Drugs Share (%), by Country
  • Figure 47. North America Pediatric Digestive Drugs Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Novartis (Switzerland)
  • Gilead Sciences Inc (United States)
  • Abbvie (Allergan) (Ireland)
  • Bristol Myers Squibb (United States)
  • Takeda (Japan)
  • Alcon Labs Inc (Switzerland)
  • Biomarin Pharm (United States)
  • Currax Pharmaceuticals LLC (United States)
  • Helsinn (Switzerland)
  • Roche Holdings (Hoffmann La Roche) (Switzerland)
Select User Access Type

Key Highlights of Report


Jul 2022 243 Pages 73 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Novartis (Switzerland), Gilead Sciences Inc (United States), Abbvie (Allergan) (Ireland), Bristol Myers Squibb (United States), Takeda (Japan), Alcon Labs Inc (Switzerland), Biomarin Pharm (United States), Currax Pharmaceuticals LLC (United States), Helsinn (Switzerland) and Roche Holdings (Hoffmann La Roche) (Switzerland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Rate of Gastronomical Diseases in young Crowd." is seen as one of major influencing trends for Pediatric Digestive Drugs Market during projected period 2021-2027.
The Pediatric Digestive Drugs market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Pediatric Digestive Drugs Market Report?